Nanologica
5,7 SEK +0,35%1 investor følger denne virksomhed
Nanologica is a biotechnology company that develops, manufactures, and sells nanoporous silica particles for life science applications. The company has two business areas: chromatography, which is an analysis and purification technique in the pharmaceutical industry used, for example in insulin, and drug development where the company develops an inhalation platform to deliver drugs locally in the lung. Nanologica was founded in 2004 and is headquartered in Södertälje.
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
NICA
Daglig lav / høj pris
5,56 / 5,7
SEK
Markedsværdi
251,82 mio. SEK
Aktieomsætning
61,3 t SEK
Volumen
11 t
Finanskalender
Delårsrapport
25.10.2024
Årsrapport
07.02.2025
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Flerie Invest AB | 39,2 % | 39,2 % |
Swedbank Robur Microcap | 5,7 % | 5,7 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
Interim Report Q2 2024 Nanologica AB (publ)
Nanologica Receives Order for NLAB Saga Valued to approximately SEK 2 Million
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools